August 21, 2024 10:47 AM EDTUpdated 03:40 PM

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

Plus, news about Retension Pharmaceuticals:

Vandria tops up Series A with another $10M: The Swiss biotech increased its round total to …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Van­dria rais­es an­oth­er $10M; Nykode ends Phase 2 tri­al in cer­vi­cal can­cer